Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells

BACKGROUND: Regulatory B cells are a newly discovered B cell subset that suppresses immune responses. Recent studies found that both anti-CD45RB and anti–Tim-1 treatments regulate immune responses by inducing regulatory B cells; however, the role of these cells in renal ischemia-reperfusion injury (...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Am Soc Nephrol
मुख्य लेखकों: Fang, Taishi, Koo, Tai Yeon, Lee, Jae-Ghi, Jang, Joon Young, Xu, Yixuan, Hwang, Ju Hee, Park, Sunjoo, Yan, Ji-Jing, Ryu, Jung-Hwa, Ryu, Yeon-Mi, Kim, Sang-Yeob, Suh, Kyung-Suk, Yang, Jaeseok
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Nephrology 2019
विषय:
Basic Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6779371/
https://ncbi.nlm.nih.gov/pubmed/31296607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018101067
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन